Assays and screens

TECHNOLOGY: Bioinformatic screens; cell-free assays

A low-cost computational method for quantifying tumor cfDNA could identify cancer patients eligible for high-cost, whole-exome sequencing-based personalized medicine. The method

Read the full 252 word article

User Sign In